dihydroxyphenylalanine has been researched along with Genetic Predisposition in 17 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "With respect to Parkinson's disease PET and later SPECT allowed the number of dopaminergic neurons to be assessed in vivo." | 2.46 | [Nuclear medicine imaging in patients with Parkinson's syndrome: an update]. ( Schwarz, J, 2010) |
| "Many different disorders have dystonia as the only or primary sign." | 2.40 | Dystonia. ( Bressman, SB, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Lopez, G | 2 |
| Eisenberg, DP | 1 |
| Gregory, MD | 1 |
| Ianni, AM | 1 |
| Grogans, SE | 1 |
| Masdeu, JC | 1 |
| Kim, J | 1 |
| Groden, C | 1 |
| Sidransky, E | 1 |
| Berman, KF | 2 |
| Dahoun, T | 2 |
| Pardiñas, AF | 2 |
| Veronese, M | 2 |
| Bloomfield, MAP | 2 |
| Jauhar, S | 2 |
| Bonoldi, I | 2 |
| Froudist-Walsh, S | 2 |
| Nosarti, C | 1 |
| Korth, C | 1 |
| Hennah, W | 1 |
| Walters, J | 1 |
| Prata, D | 1 |
| Howes, OD | 2 |
| D'Ambrosio, E | 1 |
| Rogdaki, M | 1 |
| Walters, JTR | 1 |
| July, M | 1 |
| Santhanam, P | 1 |
| Giovanella, L | 1 |
| Treglia, G | 1 |
| Schwarz, J | 1 |
| Ruprecht-Dörfler, P | 1 |
| Berg, D | 1 |
| Tucha, O | 1 |
| Benz, P | 1 |
| Meier-Meitinger, M | 1 |
| Alders, GL | 1 |
| Lange, KW | 1 |
| Becker, G | 1 |
| Hernandez, DG | 1 |
| Paisán-Ruíz, C | 1 |
| McInerney-Leo, A | 1 |
| Jain, S | 1 |
| Meyer-Lindenberg, A | 1 |
| Evans, EW | 1 |
| Johnson, J | 1 |
| Auburger, G | 1 |
| Schäffer, AA | 1 |
| Lopez, GJ | 1 |
| Nussbaum, RL | 1 |
| Singleton, AB | 1 |
| Hagenah, J | 2 |
| Saunders-Pullman, R | 1 |
| Hedrich, K | 2 |
| Kabakci, K | 1 |
| Habermann, K | 1 |
| Wiegers, K | 1 |
| Mohrmann, K | 1 |
| Lohnau, T | 1 |
| Raymond, D | 1 |
| Vieregge, P | 1 |
| Nygaard, T | 1 |
| Ozelius, LJ | 1 |
| Bressman, SB | 2 |
| Klein, C | 2 |
| Ros, R | 1 |
| Thobois, S | 2 |
| Streichenberger, N | 1 |
| Kopp, N | 1 |
| Sánchez, MP | 1 |
| Pérez, M | 1 |
| Hoenicka, J | 1 |
| Avila, J | 1 |
| Honnorat, J | 1 |
| de Yébenes, JG | 2 |
| Racette, BA | 1 |
| Good, L | 1 |
| Antenor, JA | 1 |
| McGee-Minnich, L | 1 |
| Moerlein, SM | 1 |
| Videen, TO | 1 |
| Perlmutter, JS | 1 |
| Tai, YF | 1 |
| Ahsan, RL | 1 |
| Pavese, N | 1 |
| Brooks, DJ | 2 |
| Piccini, P | 2 |
| Goldstein, DS | 1 |
| Imrich, R | 1 |
| Peckham, E | 1 |
| Holmes, C | 1 |
| Crews, C | 1 |
| Hardy, J | 1 |
| Singleton, A | 1 |
| Hallett, M | 1 |
| Binkofski, F | 1 |
| Reetz, K | 1 |
| Gaser, C | 1 |
| Hilker, R | 1 |
| van Eimeren, T | 1 |
| Thiel, A | 1 |
| Büchel, C | 1 |
| Pramstaller, PP | 1 |
| Siebner, HR | 1 |
| Anokhina, IP | 1 |
| Vertinskaia, AG | 1 |
| Vekshina, NL | 1 |
| Nebarakova, TP | 1 |
| Ovchinnikov, IV | 1 |
| Druzhina, EV | 1 |
| Ovchinnikova, OI | 1 |
| de Yebenez, J | 1 |
| Lees, AJ | 1 |
| Ceravolo, R | 1 |
| Turjanski, N | 1 |
| Pramstaller, P | 1 |
| Guillouet, S | 1 |
| Broussolle, E | 1 |
4 reviews available for dihydroxyphenylalanine and Genetic Predisposition
| Article | Year |
|---|---|
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.
Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Dihydroxyphenylalanine; Ephedrine; Fluorodeoxyglucose F18; G | 2018 |
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].
Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeox | 2010 |
Dystonia.
Topics: Age of Onset; Dihydroxyphenylalanine; Dopamine Agents; Dystonia; Dystonia Musculorum Deformans; Gene | 1998 |
Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
Topics: Aging; Animals; Antiparkinson Agents; Basal Ganglia; Brain Tissue Transplantation; Cell Transplantat | 2001 |
13 other studies available for dihydroxyphenylalanine and Genetic Predisposition
| Article | Year |
|---|---|
Longitudinal Positron Emission Tomography of Dopamine Synthesis in Subjects with GBA1 Mutations.
Topics: Adult; Aged; Case-Control Studies; Dihydroxyphenylalanine; Dopamine; Female; Gaucher Disease; Geneti | 2020 |
The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Genetic Predisposition to Disease; | 2018 |
The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.
Topics: Adult; Chromosomes, Human, Pair 10; Corpus Striatum; Cytoskeletal Proteins; Dihydroxyphenylalanine; | 2019 |
Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.
Topics: Adult; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorine Radioisotopes; Genetic Predispo | 2003 |
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.
Topics: Aged; Amino Acid Sequence; Animals; Dihydroxyphenylalanine; DNA Mutational Analysis; Family Health; | 2005 |
High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Brain; Dihydroxyphenylalanine; DNA Mutational Analysis | 2005 |
A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.
Topics: Amino Acid Substitution; Blotting, Northern; Blotting, Western; Brain; Dihydroxyphenylalanine; DNA M | 2005 |
[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies.
Topics: Adult; Aged; Aged, 80 and over; Consanguinity; Dihydroxyphenylalanine; Ethnicity; Family Health; Fem | 2006 |
Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an 18F-dopa PET study.
Topics: Aged; Amygdala; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopam | 2007 |
Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation.
Topics: Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Baroreflex; Dihydroxyphenylalanine; DNA Mut | 2007 |
Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.
Topics: Adult; Basal Ganglia Diseases; Corpus Striatum; Dihydroxyphenylalanine; DNA Mutational Analysis; Dop | 2007 |
[Hereditary alcoholism: some neurochemical and genetic mechanisms].
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcoholism; Alleles; Brain; Dihydroxyphenylalanine; DNA; Genetic Dis | 1999 |
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine Agents; Female; Fluorine Radioisotope | 2001 |